ANDA 91152, held by Luitpold Pharmaceuticals. Benztropine Mesylate.
As of Nov 22, 2026, ANDA 91152 (Benztropine Mesylate), held by Luitpold Pharmaceuticals, was first approved by FDA on Mar 29, 2010, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 29, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Benztropine Mesylate1MG/ML · injectable;injection | Benztropine Mesylate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters